At least 1,530 new Covid-19 cases and 7 related deaths were reported in UAE overnight as the country’s mass vaccination program continued.
The Ministry of Health and Prevention (MoHAP) said that with the additional cases of COVID-19, the UAE’s caseload now stands at 657,884 with 1,892 fatalities.
Health authorities have embarked on actively testing all people to enable early detection and treatment of the highly infectious disease, coupled with a massive roll out of inoculation efforts nationwide.
#UAE Reports 1,529 New COVID-19 Cases https://t.co/6IP6DgTzIl
— Asharq Al-Awsat English (@aawsat_eng) July 18, 2021
An additional 69,059 doses of the COVID-19 vaccine were administered during the past 24 hours, putting the total number of doses given at 16,263,585 or a vaccine distribution rate of 164.44 doses per 100 people.
UAE health officials have encouraged those who received both doses of the Sinopharm vaccination to receive a booster shot to further improve immune response to the virus. Research around the world is under way to determine how effective mixing vaccines is in offering greater protection against new variants of COVID-19.
An earlier evaluation of the UAE government on the anti-viral medicine Sotrovimab, which was administered to high-risk COVID-19 patients, showed that a 100 percent prevention of death among those tested and a 99 percent prevention of admission to intensive care units.
The two-week study also noted that 97 percent of the patients fully recovered within 14 days.
A clinical trial that examined the use of anti-viral medicine #Sotrovimab in the treatment of mild to moderate COVID-19 cases among high-risk patients in the #UAE found that 97 percent of its recipients fully recovered from the infection within 14 days.https://t.co/5Xhcsthw94
— Al Arabiya English (@AlArabiya_Eng) July 19, 2021
Sotrovimab, being produced by global biopharmaceutical company GlaxoSmithKline, was consequently approved for use in the UAE after the local evaluation.
This article has been adapted from its original source.